MAZE Maze Therapeutics, Inc. - 10-K
Filed Mar 25, 2026 for fiscal period ending Dec 31, 2025. See issuer overview · financials · original on SEC.gov ↗
Accession
0001193125-26-122778Signal
Material rewritefull-docYoY shift: Lean -
Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K. This filing is -0.29pp more bearish than last year's.
Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.
Per-snippet highlights
Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.
No section text extracted for this filing. The 10-K may use a non-standard template that the parser doesn't recognize - the original doc is still linked in the Stats tab.
No section text extracted for this filing. The 10-K may use a non-standard template that the parser doesn't recognize - the original doc is still linked in the Stats tab.
Material contracts, certifications & more
9 exhibits filed with this 10-K
- Exhibit 4.1: Specimen Stock Certificatemaze-ex4_1.htm · 53.2 KB
- Exhibit 10.19maze-ex10_19.htm · 781.6 KB
- Exhibit 21.1: Subsidiaries of the Registrantmaze-ex21_1.htm · 1.9 KB
- Exhibit 23.1: Consent of Independent Auditorsmaze-ex23_1.htm · 5.9 KB
- Exhibit 31.1: Rule 13a-14(a) Certification (CEO)maze-ex31_1.htm · 16.3 KB
- Exhibit 31.2: Rule 13a-14(a) Certification (CFO)maze-ex31_2.htm · 16.3 KB
- Exhibit 32.1: Section 1350 Certification (CEO)maze-ex32_1.htm · 11.6 KB
- Exhibit 32.2: Section 1350 Certification (CFO)maze-ex32_2.htm · 11.6 KB
- 0001193125-26-122778-index-headers.html0001193125-26-122778-index-headers.html
- Ticker
- MAZE
- CIK
0001842295- Form Type
- 10-K
- Accession Number
0001193125-26-122778- Filed
- Mar 25, 2026
- Period
- Dec 31, 2025 (Q4 25)
- Industry
- Biological Products, (No Diagnostic Substances)
External resources
Permalink
https://insiderdelta.com/issuers/MAZE/10-k/0001193125-26-122778